SHIP regulates the reciprocal development of T regulatory and Th17 cells

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 975-983

  Locke, Natasha R ^a   Patterson, Scott J ^a   Hamilton, Melisa J ^b   Sly, Laura M ^b   Krystal, Gerald ^b   Levings, Megan K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOIC ACID; SHIP PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; INOSITOL 1,4,5 TRISPHOSPHATE 5 PHOSPHATASE; INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; INTERLEUKIN 17; PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; TH17 CELL; WILD TYPE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; COLITIS; HOMEOSTASIS; INTERLEUKIN-17; INTERLEUKIN-6; MICE; MICE, KNOCKOUT; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 70249138405     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803749     Document Type: Article

References (43)

1. Okkenhaug, K., A. Bilancio, J. L. Emery, and B. Vanhaesebroeck. 2004. Phosphoinositide 3-kinase in T cell activation and survival. Biochem. Soc. Trans. 32: 332-335.
2. Crellin, N. K., R. V. Garcia, and M. K. Levings. 2007. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109: 2014-2022.
3. Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O'Connor, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105: 7797-7802.
4. Haxhinasto, S., D. Mathis, and C. Benoist. 2008. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205: 565-574.
5. Sly, L. M., M. J. Rauh, J. Kalesnikoff, T. Buchse, and G. Krystal. 2003. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Exp. Hematol. 31: 1170-1181.
6. Muraille, E., X. Pesesse, C. Kuntz, and C. Erneux. 1999. Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both nonhaemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem. J. 342: 697-705.
7. Lioubin, M. N., P. A. Algate, S. Tsai, K. Carlberg, A. Aebersold, and L. R. Rohrschneider. 1996. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10: 1084-1095.
8. Kiener, P. A., M. N. Lioubin, L. R. Rohrschneider, J. A. Ledbetter, S. G. Nadler, and M. L. Diegel. 1997. Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells: regulation of the association of phosphatidylinositol 3-kinase and inositol 5′-phosphatase with the antigen receptor complex. J. Biol. Chem. 272: 3838-3844.
9. -/- mice. J. Exp. Med. 191: 781-794.
10. - naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
11. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
12. Stockinger, B., M. Veldhoen, and B. Martin. 2007. Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 19: 353-361.
13. + T lymphocytes. Cell Res. 16: 902-907.
14. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
15. + Th with a minimum effect on that of Treg in the steady state. Int. Immunol. 19: 695-702.
16. + T helper cells. Cell 126: 1121-1133.
17. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
18. + T regulatory cells. J. Immunol. 178: 4022-4026.
19. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, S. H. Chang, K. S. Schluns, S. S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56.
20. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181: 2277-2284.
21. Valderrama-Carvajal, H., E. Cocolakis, A. Lacerte, E. H. Lee, G. Krystal, S. Ali, and J. J. Lebrun. 2002. Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat. Cell Biol. 4: 963-969.
22. Helgason, C. D., J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal, and R. K. Humphries. 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12: 1610-1620. (Pubitemid 28299513)
23. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
24. + CD4 T cells. Ann. NY Acad. Sci. 1103: 167-178.
25. + T cell development. J. Immunol. 176: 3958-3965.
26. Collazo, M. M., D. Wood, K. H. Paraiso, E. Lund, R. W. Engelman, C. T. Le, D. Stauch, K. Kotsch, and W. G. Kerr. 2009. SHIP limits immunoregulatory capacity in the T-cell compartment. Blood 113: 2934-2944.
27. Oliveira, V., B. Sawitzki, S. Chapman, C. Appelt, I. Gebuhr, J. Wieckiewicz, E. Long, and K. J. Wood. 2008. Anti-CD4-mediated selection of Treg in vitro: in vitro suppression does not predict in vivo capacity to prevent graft rejection. Eur. J. Immunol. 38: 1677-1688.
28. Coombes, J. L., N. J. Robinson, K. J. Maloy, H. H. Uhlig, and F. Powrie. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204: 184-194.
29. + regulatory T cells abrogates their function in vivo. J. Immunol. 177: 4376-4383.
30. Rauh, M. J., V. Ho, C. Pereira, A. Sham, L. M. Sly, V. Lam, L. Huxham, A. I. Minchinton, A. Mui, and G. Krystal. 2005. SHIP represses the generation of alternatively activated macrophages. Immunity 23: 361-374.
31. Benson, M. J., K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle. 2007. All-trans retinoic acid mediates enhanced Treg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204: 1765-1774.
32. Elias, K. M., A. Laurence, T. S. Davidson, G. Stephens, Y. Kanno, E. M. Shevach, and J. J. O'Shea. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013-1020.
33. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
34. Tarasenko, T., H. K. Kole, A. W. Chi, M. M. Mentink-Kane, T. A. Wynn, and S. Bolland. 2007. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc. Natl. Acad. Sci. USA 104: 11382-11387.
35. Chen, Z., A. Laurence, and J. J. O'Shea. 2007. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19: 400-408.
36. + regulatory T cells. J. Immunol. 177: 6598-6602.
37. + regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 19: 785-799.
38. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
39. Harris, S. J., R. V. Parry, J. Westwick, and S. G. Ward. 2008. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. J. Biol. Chem. 283: 2465-2469.
40. Bamias, G., and F. Cominelli. 2007. Immunopathogenesis of inflammatory bowel disease: current concepts. Curr. Opin. Gastroenterol. 23: 365-369.
41. Yang, Y., J. Xu, Y. Niu, J. S. Bromberg, and Y. Ding. 2008. T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J. Immunol. 181: 8700-8710.
42. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
43. + regulatory T cells. Nat. Immunol. 9: 632-640.